updated 11/22/2010 7:15:44 AM ET 2010-11-22T12:15:44

DALLAS, Nov. 22, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring MELA Sciences Inc. (Nasdaq:MELA). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

The full report is available at: www.microstockprofit.com/lp/MELA

MELA Sciences Inc. (MELA) is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company's product MelaFind, features a hand-held imaging device, which emits of light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. The data are then analyzed utilizing image processing classification algorithms, trained on the database of melanomas and benign lesions, to provide information to assist in the management of the patient, including information useful in the decision of whether to biopsy the lesion. The Company filed the MelaFind pre-market approval application with the U.S. Food and Drug Administration (FDA) in June 2009 and is under review at the FDA.

Message Board Search for MELA: http://www.boardcentral.com/boards/MELA

In the report, the analyst notes:

"MELA shares were boosted last week after an FDA panel narrowly voted in favor of its skin cancer detection device, Melafind. The General and Plastics Surgery Devices Panel appointed by the FDA voted by majority that, for its proposed indications, MelaFind is safe and effective and that its benefits outweigh the risks.

"Prior to the recommendation, the FDA expressed concerns regarding the investigational device's utility, safety and efficacy."

To read the entire report visit: www.microstockprofit.com/lp/MELA

See what investors are saying about MELA at http://www.stockhideout.com

Get breaking news on MELA at http://thestockmarketwatch.com/

MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com

MicroStockProfit.com Disclosure

MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 1.97%
$30K home equity loan FICO 5.80%
$75K home equity loan FICO 4.54%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.70%
13.70%
Cash Back Cards 17.66%
17.91%
Rewards Cards 17.05%
17.17%
Source: Bankrate.com